iPSC-based model of Vogt-Koyanagi-Harada disease for phenotype recapitulation and drug screening

Copyright © 2022. Published by Elsevier Inc.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 246(2023) vom: 10. Jan., Seite 109205
Auteur principal: Li, Wanqian (Auteur)
Autres auteurs: Tan, Jun, He, Siyuan, Yue, Yingying, Liu, Huan, Li, Ruonan, Wang, Xiaotang, Wang, Guoqing, Fan, Wei, Zhao, Chenyang, Zhou, Qian, Yang, Peizeng, Hou, Shengping
Format: Article en ligne
Langue:English
Publié: 2023
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Drug screening Early growth response gene 2 (EGR2) Induced pluripotent stem cells (iPSCs) Retinal pigment epithelium (RPE) Vogt-Koyanagi-Harada (VKH) disease